We provide you with 20 years of free, institutional-grade data for SVRA stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of SVRA. Explore the full financial landscape of SVRA stock.
Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$0
| Name | Action | Shares | Avg Price | Amount | Reported Date |
|---|---|---|---|---|---|
| Hawkins Richard J | Open Market Purchase | 48,225 | $2.04 | 2025-06-23 | |
| McCracken Joseph S | Open Market Purchase | 10,000 | $2.08 | 2025-06-02 | |
| RAMSAY DAVID A | Open Market Purchase | 150,000 | $2.77 | 2025-04-01 | |
| McCabe Kathleen R. | Initial | 2025-03-21 | |||
| Lutz Robert Matthew | Sale | -38,263 | $2.83 | $108,284 | 2025-02-14 |
| Pauls Matthew | Sale | -147,295 | $3.21 | $472,817 | 2024-12-16 |
| Pauls Matthew | Grant, award...etc | 400,000 | 2024-12-16 | ||
| Pratt Raymond Dennis | Grant, award...etc | 80,000 | 2024-12-16 | ||
| Hawkins Richard J | Sale | -8,000 | $3.32 | $26,569 | 2024-12-16 |
| Hawkins Richard J | Grant, award...etc | 40,000 | 2024-12-16 | ||
| Elam Nevan C | Grant, award...etc | 40,000 | 2024-12-16 | ||
| McCracken Joseph S | Grant, award...etc | 40,000 | 2024-12-16 | ||
| van Es-Johansson An | Grant, award...etc | 40,000 | 2024-12-16 | ||
| RAMSAY DAVID A | Grant, award...etc | 40,000 | 2024-12-16 | ||
| Lutz Robert Matthew | Grant, award...etc | 100,000 | 2024-12-16 | ||
| Lowrance David L | Sale | -49,350 | $3.21 | $158,414 | 2024-12-16 |
| Lowrance David L | Grant, award...etc | 100,000 | 2024-12-16 | ||
| Parker Braden C. | Grant, award...etc | 20,000 | 2024-12-16 | ||
| Erickson Anne | Sale | -18,263 | $3.21 | $58,624 | 2024-12-16 |
| Erickson Anne | Grant, award...etc | 100,000 | 2024-12-16 | ||
| McCracken Joseph S | Open Market Purchase | 20,000 | $2.95 | 2024-11-20 | |
| RAMSAY DAVID A | Open Market Purchase | 100,000 | $2.88 | 2024-11-18 | |
| Pratt Raymond Dennis | Sale | -49,950 | $3.97 | $198,302 | 2024-11-12 |
| Erickson Anne | Sale | -381 | $3.57 | $1,360 | 2024-10-22 |
| Parker Braden C. | Grant, award...etc | 85,000 | 2024-09-27 | ||
| Erickson Anne | Sale | -381 | $4.47 | $1,703 | 2024-07-22 |
| Erickson Anne | Sale | -381 | $4.81 | $1,833 | 2024-04-23 |
| Erickson Anne | Initial | 2024-03-29 | |||
| Lowrance David L | Sale | -10,000 | $4.71 | $47,131 | 2023-12-29 |
| Elam Nevan C | Sale | -93,843 | $4.71 | $442,291 | 2023-12-29 |
| Elam Nevan C | Derivatives Exercise | 53,758 | 2023-12-29 | ||
| Pauls Matthew | Sale | -84,000 | $4.71 | $395,900 | 2023-12-29 |
| Pratt Raymond Dennis | Grant, award...etc | 150,000 | 2023-12-18 | ||
| Lowrance David L | Grant, award...etc | 160,000 | 2023-12-15 | ||
| Lowrance David L | Sale | -30,438 | $4.45 | $135,449 | 2023-12-15 |
| Sun Ricky | Grant, award...etc | 22,500 | 2023-12-15 | ||
| Lutz Robert Matthew | Grant, award...etc | 160,000 | 2023-12-15 | ||
| Pauls Matthew | Grant, award...etc | 450,000 | 2023-12-15 | ||
| Pauls Matthew | Sale | -109,680 | $4.45 | $488,076 | 2023-12-15 |
| RAMSAY DAVID A | Grant, award...etc | 22,500 | 2023-12-15 | ||
| van Es-Johansson An | Grant, award...etc | 22,500 | 2023-12-15 | ||
| Elam Nevan C | Grant, award...etc | 22,500 | 2023-12-15 | ||
| Hawkins Richard J | Grant, award...etc | 22,500 | 2023-12-15 | ||
| McCracken Joseph S | Grant, award...etc | 22,500 | 2023-12-15 | ||
| Hawkins Richard J | Derivatives Exercise | 10,841 | 2023-12-12 | ||
| Elam Nevan C | Derivatives Exercise | 10,841 | 2023-12-12 | ||
| Walker Paul Edward | Open Market Purchase | 333,333 | $3 | 2023-07-19 | |
| SANDELL SCOTT D | Open Market Purchase | 333,333 | $3 | 2023-07-19 | |
| Makhzoumi Mohamad | Open Market Purchase | 333,333 | $3 | 2023-07-19 | |
| Mathers Edward T | Open Market Purchase | 333,333 | $3 | 2023-07-19 | |
| Chang Carmen | Open Market Purchase | 333,333 | $3 | 2023-07-19 | |
| BASKETT FOREST | Open Market Purchase | 333,333 | $3 | 2023-07-19 | |
| Florence Anthony A. Jr. | Open Market Purchase | 333,333 | $3 | 2023-07-19 | |
| Behbahani Ali | Open Market Purchase | 333,333 | $3 | 2023-07-19 | |
| Growth Equity Opportunities 17, LLC | Open Market Purchase | 333,333 | $3 | 2023-07-19 | |
| Yang Rick | Open Market Purchase | 333,333 | $3 | 2023-07-19 | |
| Pratt Raymond Dennis | Open Market Purchase | 6,500 | $2.93 | 2023-06-27 | |
| RAMSAY DAVID A | Open Market Purchase | 100,000 | $2.56 | 2023-05-26 | |
| Lutz Robert Matthew | Grant, award...etc | 140,000 | 2023-02-28 | ||
| RAMSAY DAVID A | Open Market Purchase | 36,000 | $1.54 | 2023-01-03 | |
| RAMSAY DAVID A | Open Market Purchase | 19,000 | $1.44 | 2022-12-28 | |
| Pratt Raymond Dennis | Open Market Purchase | 3,500 | $1.54 | 2022-12-22 | |
| RAMSAY DAVID A | Open Market Purchase | 45,000 | $1.48 | 2022-12-22 | |
| RAMSAY DAVID A | Open Market Purchase | 54,890 | $1.5 | 2022-12-20 | |
| Elam Nevan C | Derivatives Exercise | 1,172 | 2022-12-15 | ||
| Lowrance David L | Grant, award...etc | 100,000 | 2022-12-15 | ||
| Pauls Matthew | Grant, award...etc | 325,000 | 2022-12-15 | ||
| Hawkins Richard J | Derivatives Exercise | 1,172 | 2022-12-08 | ||
| RAMSAY DAVID A | Open Market Purchase | 20,105 | $1.42 | 2022-11-25 | |
| Pratt Raymond Dennis | Grant, award...etc | 150,000 | 2022-11-22 | ||
| RAMSAY DAVID A | Open Market Purchase | 50,005 | $1.27 | 2022-11-21 | |
| RAMSAY DAVID A | Open Market Purchase | 135,000 | $1.42 | 2022-09-27 | |
| RAMSAY DAVID A | Open Market Purchase | 8,000 | $1.44 | 2022-09-20 | |
| RAMSAY DAVID A | Open Market Purchase | 32,000 | $1.38 | 2022-09-08 | |
| RAMSAY DAVID A | Open Market Purchase | 100,000 | $1.41 | 2022-09-01 | |
| RAMSAY DAVID A | Open Market Purchase | 100,000 | $1.33 | 2022-06-22 | |
| Pauls Matthew | Sale | -62,318 | $1.24 | $77,274 | 2022-01-03 |
| RAMSAY DAVID A | Open Market Purchase | 50,000 | $1.25 | 2021-12-30 | |
| Lowrance David L | Open Market Purchase | 4,000 | $1.14 | 2021-12-17 | |
| RAMSAY DAVID A | Open Market Purchase | 40,000 | $1.08 | 2021-12-17 | |
| Lowrance David L | Grant, award...etc | 125,000 | 2021-12-14 | ||
| Hawkins Richard J | Derivatives Exercise | 728 | 2021-12-14 | ||
| Chowdhury Badrul A. | Grant, award...etc | 125,000 | 2021-12-14 | ||
| Pauls Matthew | Grant, award...etc | 400,000 | 2021-12-14 | ||
| RAMSAY DAVID A | Open Market Purchase | 35,000 | $1.04 | 2021-12-13 |
The information provided in this report about SVRA stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Savara Inc(NASDAQ:SVRA) 
Savara Inc. operates as an orphan lung disease company. Its lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase III development stage for the treatment of autoimmune pulmonary alveolar proteinosis. The company is headquartered in Aus...
Website: http://www.savarapharma.com
Founded: 1995
Full Time Employees: 36
Sector: Healthcare
Industry: Biotechnology